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ABSTRACT
Background Direct aspiration thrombectomy 
techniques use large bore aspiration catheters for 
mechanical thrombectomy. Several aspiration catheters 
are now available. We report a bench top exploration 
of a novel beveled tip catheter and our experience 
in treating large vessel occlusions (LVOs) using next- 
generation aspiration catheters.
Methods A retrospective analysis from a prospectively 
maintained database comparing the bevel shaped tip 
aspiration catheter versus non- beveled tip catheters was 
performed. Patient demographics, periprocedural metrics, 
and discharge and 90- day modified Rankin Scale (mRS) 
scores were collected. Patients were divided into two 
groups based on which aspiration catheter was used.
Results Our data showed no significant difference 
in age, gender, IV tissue plasminogen activator 
administration, admission NIH Stroke Scale score, 
baseline mRS, or LVO location between the beveled tip 
and flat tip groups. With the beveled tip, Thrombolysis in 
Cerebral Infarction (TICI) 2C or better recanalization was 
more frequent overall (93.2% vs 74.2%, p=0.017), stent 
retriever usage was lower (9.1% vs 29%, p=0.024), and 
patients had lower mRS on discharge (median 3 vs 4, 
p<0.001) and at 90 days (median 2 vs 4, p=0.008).
Conclusion Patients who underwent mechanical 
thrombectomy with the beveled tip catheter had a higher 
proportion of TICI 2C or better and had a significantly 
lower mRS score on discharge and at 90 days.
INTRODUCTION
In recent years several trials have established 
mechanical thrombectomy as a treatment option in 
patients with large vessel occlusions.1–8 While many 
of these trials used stent retrievers to achieve reca-
nalization, recent data suggest that direct aspiration 
as a first pass approach is a viable alternative to 
stent retriever- based methods.9–11 Direct aspiration 
thrombectomy uses a large bore aspiration catheter 
to aspirate the thrombus without the use of a stent 
retriever. If aspiration is unsuccessful, the large bore 
aspiration catheter can serve as a platform to deliver 
a stent retriever or other devices.12–14
The renewed interest in mechanical thrombec-
tomy has led to the rapid evolution of catheter tech-
nology, with several large bore aspiration catheters 
now available. Suction force at the tip of an aspi-
ration catheter is thought to be a crucial factor in 
the success of aspiration thrombectomy, and since 
the force at the catheter tip is directly proportional 
to the cross- sectional area of the catheter tip, many 
newer generation catheters feature a larger catheter 
tip diameter.15–17 Additionally, an aspiration cath-
eter with a beveled tip design has recently been 
developed (figure 1). We report our initial clinical 
experience in treating large vessel occlusions using 
these next- generation aspiration catheters.
METHODS
Clinical data
A retrospective analysis from a prospectively 
maintained database was performed on patients 
undergoing stroke thrombectomy for large vessel 
occlusions (middle cerebral artery (MCA) M1 and 
proximal M2 segments, vertebral or basilar arteries, 
or the carotid terminus) with direct aspiration 
thrombectomy at our institution from November 
2018 until May 2020 using an institutional review 
board- approved protocol. Specific parameters 
captured included age, gender, whether the patient 
received IV tissue plasminogen activator (tPA), pre- 
hospital modified Rankin Scale (mRS) score, admis-
sion NIH Stroke Scale (NIHSS) score, the location 
of the vascular occlusion, and Thrombolysis in 
Cerebral Ischemia (TICI) flow post procedure. The 
number of aspiration attempts ('passes') made to 
achieve recanalization of the target vessel and the 
number of passes made to achieve TICI 2B flow or 
better and TICI 2C flow or better were recorded, 
and if a stent retriever was used. Discharge mRS and 
90- day mRS scores were collected where available.
All operators selected patients for thrombectomy 
according to their usual practice. Direct aspiration 
thrombectomy has been previously described.12 13 
Briefly, access to the cerebral vasculature requires 
a 6 French guide catheter. This is advanced as far 
distally into the internal carotid artery as is safely 
possible. For posterior circulation thrombi, the 
guide catheter is navigated into the largest caliber 
vertebral artery and positioned into the distal V2 
segment. A large bore aspiration catheter is navi-
gated to the level of the thrombus over any micro-
catheter and microwire the operator chooses. 
Aspiration is applied by use of an aspiration pump. 
Inability to draw back on aspiration confirms the 
optimal position of the aspiration catheter abut-
ting the thrombus. At this point, the catheter is 
slightly advanced to ensure firm engagement with 
the thrombus, and under aspiration the catheter is 
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The large bore aspiration catheters used at our center during 
the study period included the JET7 (Penumbra, Alameda, Cali-
fornia, USA), React71 (Medtronic, Minneapolis, Minnesota, 
USA), Large Bore Catheter (Cerenovus, Irvine California, USA), 
Vecta (Stryker Neurovascular, Kalamazoo Michigan, USA), and 
Sofia Plus (Microvention, Aliso Viejo, California, USA). Addi-
tionally, beginning in October 2019, the beveled tip Zoom71 
(Imperative Care, Campbell, California, USA) catheter was used. 
Additional devices were used at the discretion of the operator if 
first pass failed.
In vitro experiment
To study mechanistically the effect of the beveled tip aspiration 
catheter, we used a vascular phantom with flow conditions as 
previously described.18 To remove confounding variables, a 
simple tapering tube bent 90° was used as the vascular phantom 
in which a clot model consisting of thrombin- induced clotting of 
bovine blood (2.5 NIHU thrombin/mL blood) with the addition 
of fibrinogen (9 mg/mL blood) and calcium- phosphate apatite 
(44 mg/mL blood) was introduced to create a large vessel occlu-
sion.19 The clot measured 3.2 mm in diameter and was 7 mm 
in length. Flow conditions mimicked those typically found in 
the human MCA.20 Twenty experiments were conducted with 
either a Sofia Plus or a Zoom71, randomized one- to- one per 
device (each device was operated in 10 replicate experiments). 
We recorded the rate of complete ingestion within the catheter 
versus corking the clot at the catheter tip followed by retrac-
tion. We further measured the rate of complete recanalization 
after a single attempt. Finally, using a closed system and digital 
manometer, we recorded the pressure at the catheter tip for 
both devices, as previously described.21 Aspiration was gener-
ated using a commercially available vacuum pump (Stryker 
Neurovascular).
Statistical analysis
Patients were grouped depending on which large bore aspiration 
catheter was used for thrombectomy. We compared the baseline 
characteristics of patients such as age, sex, baseline mRS score, 
and IV tPA administration. The number of attempts to recanalize 
the target vessel, the number of attempts to achieve TICI 2B or 
better and TICI 2C or better, and whether a stent retriever was 
used were analyzed. The number of attempts during each proce-
dure were recorded. When comparing all catheters, continuous 
variables are reported as mean±SD or median (interquartile 
range) and were tested using a one- way ANOVA or Kruskal–
Wallis test, respectively. Discrete variables are reported as 
number (%) and tested using a χ2 test or Fisher’s exact test for 
small sample sizes (n<5).
Additionally, we grouped patients into those who underwent a 
thrombectomy using the beveled tip catheter and those in whom 
the flat tip catheters were used. For these analyses, continuous 
variables were tested using the Student’s t- test or Wilcoxon 
rank- sum test, and discrete variables were tested using a χ2 test 
or Fisher’s exact test. Values of p<0.05 were considered statisti-
cally significant. All analyses were carried out using R statistical 
software (The R Foundation, version 4.0.2).
RESULTS
Patient characteristics
There was no significant difference in age, sex, rate of IV tPA 
administration, and admission NIHSS scores between the 
beveled tip and flat tip groups (table 1), nor was there a differ-
ence between baseline mRS scores between the two groups 
(table 2). There was no significant difference in the location of 
vessel occlusion (table 3).
Recanalization efficacy
Recanalization efficacy is summarized in table 4. The percentage 
of cases in which a stent retriever was used as a rescue device was 
significantly lower in cases where the beveled tip catheter was 
used (9.1% vs 29%, p=0.024). Overall, TICI 2C was achieved in 
significantly more cases with the beveled tip catheter compared 
with the flat tip catheters (93.2% vs 74.2%, p=0.017). The 
beveled tip catheter was able to achieve TICI 2C or better on 
first pass in 58.5% of cases compared with 49.3% of cases with 
flat tip catheters. In cases where TICI 2C or better outcomes 
were achieved, there was no significant difference between 
the percentage of patients who received IV tPA (48.8% for the 
beveled tip catheter vs 37.7% for the flat tip catheters). There 
was a trend towards a higher percentage of one pass thrombec-
tomies with the beveled tip catheter compared with the flat tip 
catheters (56.8% vs 39.8%), but this did not reach statistical 
significance. When compared with flat tip catheters, the number 
of passes per procedure was also lower with the beveled tip cath-
eter (1.978 vs 2.47).
Complications
There were four non- access site- related intraprocedural compli-
cations, consisting of three dissections and one perforation. 
There were no complications related to the aspiration catheters 
in either group.
Figure 1 The Zoom71 reperfusion catheter with a beveled tip. Image 
courtesy of Imperative Care (reprinted with permission).
Table 1 Patient demographics for the beveled tip catheter group 
versus the flat tip catheter group
Beveled Flat P value
N 44 93
Age, mean±SD 69.4±14.4 67.0±15.8 0.372
Sex, n (%) 0.713
  Women 21 (47.73) 40 (43.01)
  Men 23 (52.27) 53 (56.99)
tPA, n (%) 22 (50) 37 (39.78) 0.274
Admission NIHSS score 44 91
  Median (IQR) 17 (14–21) 19 (15–23) 0.082
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Outcomes
Table 2 compares mRS scores of patients on admission, at 
discharge, and at 90 days between flat tip and beveled tip cathe-
ters. In the beveled tip group the baseline mRS score was avail-
able in 42 of 44 cases (95.6%), the discharge mRS was available 
in all 44 cases (100%), and the 90- day mRS score was avail-
able in 28 of 44 cases (63.3%). In the flat tip catheter group the 
baseline mRS score was available in 68 of 93 cases (73.1%), the 
discharge mRS score was available in 91 of 93 cases (97.8%), and 
the 90- day mRS score was available in 81 of 93 cases (87.1%). In 
cases where data were obtained, patients who underwent throm-
bectomy with the beveled tip catheter had a significantly lower 
mRS score on discharge (median 3 vs 4, p<0.001) and at 90 days 
(median 2 vs 4, p=0.008).
In vitro study
The vacuum generated at the tip of the Sofia and Zoom cathe-
ters was the same (631±8 mmHg, p=0.97). The force acting to 
remove the clot is linearly proportional to the area of the cath-
eter tip, and therefore 15% larger for the Zoom71 device due to 
the bevel tip.15 This larger force resulted in complete ingestion 
of the clot within the Zoom71 catheter in 90% of the experi-
ments compared with 20% of the experiments with the control 
device (p=0.006). In the one case of failed complete ingestion 
for the Zoom71 catheter, the angled tip was not oriented 180° 
with the long axis of the clot. With both devices, complete reca-
nalization was achieved on first pass.
DISCUSSION
We sought to evaluate the effect of a beveled tip aspiration cath-
eter by comparing the performance of similar sized flat tip cath-
eters with the beveled tip Zoom71 catheter. Our results show 
that, when the beveled tip catheter was used, there was an asso-
ciated lower number of total aspiration attempts, reduced stent 
retriever usage, more frequent TICI 2C or better recanalization, 
and a lower discharge and 90- day mRS score.
There is evidence that a larger aspiration catheter tip surface 
area leads to an increase in aspiration power at the tip, an effect 
that has been postulated to be responsible for a higher first 
pass efficacy in cardiac thrombectomy.22 23 However, there is 
some debate concerning the impact of larger bore catheters on 
outcomes.24 In acute ischemic stroke, mechanical thrombectomy 
performed with the ACE68 catheters also demonstrated higher 
first pass efficacy compared with the early generation ACE60 
and ACE64 catheters.15 16 This has led to the development of 
newer, larger bore aspiration catheters in the 0.071–0.074 inch 
range. However, with increasing catheter size there is a trade 
off with navigability into the intracranial vasculature, as larger 
catheters will eventually be too large to navigate smaller intra-
cranial vessels. One strategy to mitigate this limitation is to intro-
duce a beveled tip catheter, which allows for a higher surface 
area without necessitating an overall larger diameter catheter 
(table 5).
Force can be described mathematically by:
 F = P ∗ A 
Table 2 Modified Rankin Scale (mRS) scores on admission, at 
discharge, and at 90 days for flat tip and beveled tip catheter groups
Beveled (n)
Beveled mRS
Median (IQR) Flat (n)
Flat mRS
Median (IQR) P value
Admission 42 0 (0–1) 68 0 (0–1) 0.698
Discharge 44 3 (2–4) 91 4 (3–5) <0.001
90 Days 28 2 (1–3) 81 4 (2–6) 0.008
Bold text denotes statistically significant findings.
Table 3 Anatomical locations of vessel occlusion in the flat tip and 
beveled tip catheter groups
Beveled Flat P value
Total 44 93
Target vessel, n (%) 0.423
  Basilar 2 (4.55) 8 (8.6)
  LICA 5 (11.36) 15 (16.13)
  LM1 18 (40.91) 24 (25.81)
  LM2 5 (11.36) 8 (8.6)
  RICA 0 (0) 10 (10.75)
  RM1 3 (6.82) 21 (22.58)
  RM2 11 (25) 6 (6.45)
  R Vertebral (V4 segment) 0 (0) 1 (1.08)
Table 4 Thrombectomy results: total number of passes, number 
of single passes to achieve target recanalization, stent retriever 
utilization, number of passes to achieve TICI 2B or better and TICI 2C or 
better, one pass versus multiple passes for target vessel recanalization
Beveled Flat p- value
Number 44 93
All cases
  Number of passes 87 230
  One pass, n (%) 25 (56.82) 37 (39.78) 0.069
  Mean±SD 2.0±1.4 2.5±1.8 0.079
  Stent retriever, n (%) 4 (9.09) 27 (29.03) 0.024
TICI 2B or better
  n 44 (100) 87 (93.55) 0.177
  One pass, n (%)* 25 (56.82) 36 (41.38) 0.100
TICI 2C or better
  n (%) 41 (93.18) 69 (74.19) 0.017
  One pass, n (%)† 24 (58.54) 34 (49.28) 0.430
  tPA, n (%)† 20 (48.78) 26 (37.68) 0.318
  Stent retriever, n (%)† 4 (9.76) 15 (21.74) 0.193
Bold text denotes statistically significant findings.
*Reference denominator is number of TICI 2B+.
†Reference denominator is number of TICI 2C+.
TICI, Thrombolysis in Cerebral Infarction; tPA, tissue plasminogen activator.
Table 5 Comparison of catheter inner diameters (ID) and area of 
catheter tip
Catheter
Catheter cross- sectional 
ID (mm)
Area of catheter tip 
opening (mm2)
Jet7 1.83 2.63
Large Bore Catheter 1.80 2.55
React71 1.80 2.55
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where F is force, P is pressure, and A is area. Therefore, an 
increase in area is directly proportional to an increase in force. 
Our in vitro model showed that force acting to remove the clot is 
15% larger for the Zoom71 device due to the bevel tip.15
Another factor that has been linked to the success of throm-
bectomy in the anterior circulation is the amount of vessel 
curvature.25 A retrospective review of 159 patients found that 
mechanical thrombectomy for acute ischemic stroke using stent 
retrievers was less successful in patients with strongly curved M1 
segments.26 In the cardiac literature, the success of aspiration 
thrombectomy has also been linked to vessel curvature, with 
more success in straighter segments.27 The angle of interaction 
between the aspiration catheter and the thrombus has been 
found to impact the success of mechanical thrombectomy, with 
an angle of interaction of greater than 125.5 degrees (ie, cath-
eter tip more in line with thrombus face) associated with higher 
success in clot removal.28 We propose that a beveled tip catheter 
allows for better alignment along the vessel wall and a higher 
angle of interaction with the thrombus face. In the in vitro study 
there was one case of failed complete ingestion for the beveled 
tip catheter in which the angled tip was not oriented 180° with 
the long axis of the clot, further supporting the role of the angle 
of interaction.
First pass efficacy has been postulated to be an important 
measure of procedural success, as reports suggest a correlation 
between first pass success and good clinical outcomes.16 In terms 
of first pass efficacy, the target vessel was successfully recanalized 
to TICI 2B or better with one attempt in 56.8% of cases with the 
beveled tip catheter compared with 41.4% with comparable flat 
tip catheters, although this did not reach statistical significance. 
While TICI 2B or better has historically been used as a measure 
of success, we feel that improvements in technology now allow 
TICI 2C to be achieved in the majority of cases and that this 
should be the minimal procedural outcome goal that is accepted. 
The first pass efficacy for TICI 2C or better recanalization was 
slightly higher for the beveled tip catheter group (58.5% vs 
49.3%), and while this was also not a significant difference, it 
suggests that in cases where TICI 2C or better was not achieved 
on the first pass, the beveled tip catheter served as a viable plat-
form to deliver smaller aspiration catheters or stent retrievers 
with which to pursue downstream emboli. The overall TICI 2C 
or better efficacy with the beveled tip catheter of 93.2% was 
further supported by the overall lower average number of aspi-
ration attempts and the lower percentage of stent retriever use, 
which in our practice is used as a second or third line option. 
The higher percentage of cases achieving TICI 2C or better in 
the beveled tip catheter group could be an important factor in 
the significantly lower discharge and 90- day mRS scores seen in 
the beveled tip catheter group. Finally, a decrease in the number 
of cases in which a stent retriever was used implies cost savings, 
which we did not investigate in this study.
Limitations
Our study has several limitations. The in vitro model is a simplistic 
vascular phantom that had 100% first pass success regardless of 
device. However, both devices were exposed to identical condi-
tions to remove numerous confounding variables to study the 
mechanism by which the beveled catheter tip engages clot. Our 
clinical experience is a single- center retrospective experience 
and the data reported here are observational in nature. A small 
number of cases were performed with the LBC, Sofia, and the 
Vecta, which precludes any meaningful conclusions about the 
individual performance of these catheters. However, there is 
no evidence to suggest that there should be a difference in clot 
ingestion performance due to similar device construction and 
design.
CONCLUSION
We found the unique design of the Zoom71 beveled tip aspira-
tion catheter appears to translate clinically into a more efficacious 
thrombectomy device with improved functional outcomes. This 
is the only study to date detailing this novel device. While the 
observations are from a single center, the differences observed 
are significant and warrant a larger multicenter study.
Contributors JV, JB, and AV collected the data and drafted and revised the paper. 
VA, RMK, and MJG performed the benchtop experiment as well as revised the draft 
paper. JAE performed the statistical analysis and reviewed the paper. RDT, IC, and AT 
revised the draft paper.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not- for- profit sectors.
Competing interests JV is a consultant for Integra Life Sciences and Corindus 
Vascular Robotics. MJG has received research support from the National Institutes 
of Health (NIH), the United States – Israel Binational Science Foundation, Anaconda, 
Apic Bio, Arsenal Medical, Axovant, Cerenovus, Ceretrieve, Cook Medical, Galaxy LLC, 
Gentuity, Imperative Care, InNeuroCo, Insera, Magneto, Microvention, Medtronic 
Neurovascular, MIVI Neurosciences, Neuravi, Neurogami, Philips Healthcare, 
Progressive Neuro, Rapid Medical, Route 92 Medical, Stryker Neurovascular, 
Syntheon, ThrombX Medical and the Wyss Institute; is a consultant on a fee- per- hour 
basis for Cerenovus, Imperative Care, Medtronic Neurovascular, Mivi Neurosciences, 
Phenox, Q’Apel Medical, Route 92 Medical, and Stryker Neurovascular; holds stock 
in Imperative Care, InNeuroCo, and Neurogami. RDT is a consultant for Siemens 
Healthineers, Johnson and Johnson, Q’Apel Medical, Rebound Therapeutics, 
Echovate, Viseon; holds stock in Q’Apel Medical, Rebound Therapeutics, Echovate, 
Viseon, Synchron, Endostream Medical, and receives royalty fees from the Medical 
University of South Carolina. IC is a consultant for Terumo Microvention, Johnson 
and Johnson, Imperative Care, Medtronic Neurovascular; holds stock in Q’Apel 
Medical, RIST Neurovascular, Echovate, Viseon, Synchron, Endostream Medical, and 
receives royalty fees from the Medical University of South Carolina. AT is a consultant 
for Blockade Medical, Cardinal Consulting, Cerebrotech, Corindus Vascular Robotics, 
Medtronic Neurovascular, Endostream Medical, Terumo Microvention, Penumbra, 
Siemens Healthineers, Imperative Care, Three Rivers Medical, Vastrax, Shape Memory, 
Stryker Neurovascular, Serenity Medical, 880 Medical, Q’Apel Medical; holds stock in 
Cerebrotech, Corindus Robotics, Endostream Medical, Imperative Care, Three Rivers 
Medical, Vastrax, Shape Memory, Synchron, Serenity Medical, BlinkTBI, Echovate, 
RIST, Apama, Pipe Therapeutics; is the Chief Medical Officer of Corindus Robotics, 
Imperative Care; is the co- founder of Imperative Care, Vastrax, National Education 
and Research (NEAR) Center, Neuro Technology Investors (NTI), Pipe Therapeutics; is 
a board member of BlinkTBI.
Patient consent for publication Not required.
Ethics approval Prisma Health Upstate IRB - Pro00103652.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request. Please 
contact the corresponding author for data requests.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iDs
Jan Vargas http:// orcid. org/ 0000- 0001- 7164- 1479
Rrobert M King http:// orcid. org/ 0000- 0002- 5144- 9110
REFERENCES
 1 Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial 
treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20.
 2 Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid 
endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30.
 3 Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom 
onset in ischemic stroke. N Engl J Med 2015;372:2296–306.
 4 Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke 
with perfusion- imaging selection. N Engl J Med 2015;372:1009–18.
 5 Saver JL, Goyal M, Bonafe A, et al. Stent- retriever thrombectomy after intravenous 






















5Vargas J, et al. J NeuroIntervent Surg 2020;0:1–5. doi:10.1136/neurintsurg-2020-016695
Ischemic stroke
 6 Demchuk AM, Goyal M, Menon BK, et al. Endovascular treatment for small core 
and anterior circulation proximal occlusion with emphasis on minimizing CT to 
recanalization times (ESCAPE) trial: methodology. Int J Stroke 2015;10:429–38.
 7 Mocco J, Zaidat OO, von Kummer R, et al. Aspiration thrombectomy after intravenous 
alteplase versus intravenous alteplase alone. Stroke 2016;47:2331–8.
 8 Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous 
alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. 
Lancet Neurol 2016;15:1138–47.
 9 Turk AS, Siddiqui AH, Mocco J. A comparison of direct aspiration versus stent retriever 
as a first approach (’COMPASS’): protocol. J Neurointerv Surg 2018;10:953–7.
 10 Turk AS, Siddiqui A, Fifi JT, et al. Aspiration thrombectomy versus stent retriever 
thrombectomy as first- line approach for large vessel occlusion (COMPASS): a 
multicentre, randomised, open label, blinded outcome, non- inferiority trial. The Lancet 
2019;393:998–1008.
 11 Lapergue B, Blanc R, Gory B, et al. Effect of endovascular contact aspiration vs stent 
retriever on revascularization in patients with acute ischemic stroke and large vessel 
occlusion: the ASTER randomized clinical trial. JAMA 2017;318:443–52.
 12 Turk AS, Spiotta A, Frei D, et al. Initial clinical experience with the ADAPT technique: 
a direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg 
2014;6:231–7.
 13 Turk AS, Frei D, Fiorella D, et al. ADAPT FAST study: a direct aspiration first pass 
technique for acute stroke thrombectomy. J Neurointerv Surg 2014;6:260–4.
 14 Vargas J, Spiotta A, Fargen K, et al. Long term experience using the ADAPT technique 
for the treatment of acute ischemic stroke. J Neurointerv Surg 2017;9:437–41.
 15 Hu YC, Stiefel MF. Force and aspiration analysis of the ADAPT technique in acute 
ischemic stroke treatment. J Neurointerv Surg 2016;8:244–6.
 16 Delgado Almandoz JE, Kayan Y, Wallace AN, et al. Larger ACE 68 aspiration catheter 
increases first- pass efficacy of ADAPT technique. J Neurointerv Surg 2019;11:141–6.
 17 Gross BA, Jadhav AP, Jovin TG, et al. Clinical comparison of new generation 0.071- 
inch and 0.072- inch aspiration catheters. World Neurosurg 2019;130:e463–6.
 18 Arslanian RA, Marosfoi M, Caroff J, et al. Complete clot ingestion with cyclical ADAPT 
increases first- pass recanalization and reduces distal embolization. J Neurointerv Surg 
2019;11:931–6.
 19 Chueh J, Lichtman J, Arslanian R. Characteristics of clots from acute ischemic stroke 
and laboratory analogs. UMass Center for Clinical and Translational Science Research 
Retreat, 2017.
 20 Chueh JY, Wakhloo AK, Gounis MJ. Effectiveness of mechanical endovascular 
thrombectomy in a model system of cerebrovascular occlusion. AJNR Am J 
Neuroradiol 2012;33:1998–2003.
 21 Simon SD, Grey CP. Hydrodynamic comparison of the penumbra system and 
commonly available syringes in forced- suction thrombectomy. J Neurointerv Surg 
2014;6:205–11.
 22 Rioufol G, Collin B, Vincent- Martin M, et al. Large tube section is the key to successful 
coronary thrombus aspiration: findings of a standardized bench test. Catheter 
Cardiovasc Interv 2006;67:254–7.
 23 Boisseau W, Escalard S, Fahed R, et al. Direct aspiration stroke thrombectomy: 
a comprehensive review. J Neurointerv Surg 2020. doi:10.1136/
neurintsurg-2019-015508. [Epub ahead of print: 12 Jun 2020].
 24 Tonetti DA, Desai SM, Casillo S, et al. Large- bore aspiration catheter selection does 
not influence reperfusion or outcome after manual aspiration thrombectomy. J 
Neurointerv Surg 2019;11:637–40.
 25 Zhu L, Liebeskind DS, Jahan R, et al. Thrombus branching and vessel curvature are 
important determinants of middle cerebral artery trunk recanalization with Merci 
thrombectomy devices. Stroke 2012;43:787–92.
 26 Schwaiger BJ, Gersing AS, Zimmer C, et al. The curved MCA: influence of vessel 
anatomy on recanalization results of mechanical thrombectomy after acute ischemic 
stroke. AJNR Am J Neuroradiol 2015;36:971–6.
 27 Pioud V, Lorgis L, Collin B, et al. Coronary thrombectomy, technical comparison of 
two systems on a laboratory bench: the impact of bends, angles and thrombus age. 
EuroIntervention 2011;6:729–34.
 28 Bernava G, Rosi A, Boto J, et al. Direct thromboaspiration efficacy for mechanical 
thrombectomy is related to the angle of interaction between the aspiration catheter 

















urg: first published as 10.1136/neurintsurg-2020-016695 on 6 O
ctober 2020. D
ow
nloaded from
 
